Similar articles for PMID: 22363544

Year	Number of Results
1996	1
2000	1
2002	2
2003	4
2004	2
2005	2
2006	1
2007	1
2008	1
2009	4
2010	3
2011	7
2012	6
2013	6
2014	11
2015	9
2016	10
2017	7
2018	6
2019	8
2020	5
2021	7
2022	1
2024	0

1

Pneumococcal antibody concentrations and carriage of pneumococci more than 3 years after infant immunization with a pneumococcal conjugate vaccine.

Akinsola AK, Ota MO, Enwere GC, Okoko BJ, Zaman SM, Saaka M, Nsekpong ED, Odutola AA, Greenwood BM, Cutts FT, Adegbola RA. Akinsola AK, et al. PLoS One. 2012;7(2):e31050. doi: 10.1371/journal.pone.0031050. Epub 2012 Feb 20. PLoS One. 2012. PMID: 22363544 Free PMC article.

2

The effect of an alternative reduced-dose infant schedule and a second year catch-up schedule with 7-valent pneumococcal conjugate vaccine on pneumococcal carriage: a randomized controlled trial.

Dagan R, Givon-Lavi N, Porat N, Greenberg D. Dagan R, et al. Vaccine. 2012 Jul 20;30(34):5132-40. doi: 10.1016/j.vaccine.2012.05.059. Epub 2012 Jun 6. Vaccine. 2012. PMID: 22683519 Clinical Trial.

3

Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian children who participated in a 9-valent pneumococcal conjugate vaccine trial and in their younger siblings.

Cheung YB, Zaman SM, Nsekpong ED, Van Beneden CA, Adegbola RA, Greenwood B, Cutts FT. Cheung YB, et al. Pediatr Infect Dis J. 2009 Nov;28(11):990-5. doi: 10.1097/INF.0b013e3181a78185. Pediatr Infect Dis J. 2009. PMID: 19536041 Clinical Trial.

4

Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal carriage in newborns in rural Gambia: a randomised controlled trial.

Egere U, Townend J, Roca A, Akinsanya A, Bojang A, Nsekpong D, Greenwood B, Adegbola RA, Hill PC. Egere U, et al. PLoS One. 2012;7(11):e49143. doi: 10.1371/journal.pone.0049143. Epub 2012 Nov 21. PLoS One. 2012. PMID: 23185303 Free PMC article. Clinical Trial.

5

The Antibody Response Following a Booster With Either a 10- or 13-valent Pneumococcal Conjugate Vaccine in Toddlers Primed With a 13-valent Pneumococcal Conjugate Vaccine in Early Infancy.

Trück J, Jawad S, Goldblatt D, Roalfe L, Snape MD, Voysey M, Pollard AJ. Trück J, et al. Pediatr Infect Dis J. 2016 Jul;35(7):787-93. doi: 10.1097/INF.0000000000001180. Pediatr Infect Dis J. 2016. PMID: 27088583 Free article. Clinical Trial.

6

Serotype-Specific Correlates of Protection for Pneumococcal Carriage: An Analysis of Immunity in 19 Countries.

Voysey M, Fanshawe TR, Kelly DF, O'Brien KL, Kandasamy R, Shrestha S, Thorson S, Hinds J, Pollard AJ. Voysey M, et al. Clin Infect Dis. 2018 Mar 5;66(6):913-920. doi: 10.1093/cid/cix895. Clin Infect Dis. 2018. PMID: 29069415 Clinical Trial.

7

Pneumococcal conjugate vaccine induced IgG and nasopharyngeal carriage of pneumococci: Hyporesponsiveness and immune correlates of protection for carriage.

Ojal J, Hammitt LL, Gaitho J, Scott JAG, Goldblatt D. Ojal J, et al. Vaccine. 2017 Aug 16;35(35 Pt B):4652-4657. doi: 10.1016/j.vaccine.2017.05.088. Epub 2017 Jul 21. Vaccine. 2017. PMID: 28739116 Free PMC article. Clinical Trial.

8

Declining serotype coverage of new pneumococcal conjugate vaccines relating to the carriage of Streptococcus pneumoniae in young children.

Tocheva AS, Jefferies JM, Rubery H, Bennett J, Afimeke G, Garland J, Christodoulides M, Faust SN, Clarke SC. Tocheva AS, et al. Vaccine. 2011 Jun 10;29(26):4400-4. doi: 10.1016/j.vaccine.2011.04.004. Epub 2011 Apr 17. Vaccine. 2011. PMID: 21504773

9

Serotype-specific avidity is achieved following a single dose of the 7-valent pneumococcal conjugate vaccine, and is enhanced by 23-valent pneumococcal polysaccharide booster at 12 months.

Russell FM, Balloch A, Licciardi PV, Carapetis JR, Tikoduadua L, Waqatakirewa L, Cheung YB, Mulholland EK, Tang ML. Russell FM, et al. Vaccine. 2011 Jun 15;29(27):4499-506. doi: 10.1016/j.vaccine.2011.04.038. Epub 2011 May 1. Vaccine. 2011. PMID: 21539882 Free PMC article. Clinical Trial.

10

Immunogenicity, otitis media, hearing impairment, and nasopharyngeal carriage 6-months after 13-valent or ten-valent booster pneumococcal conjugate vaccines, stratified by mixed priming schedules: PREVIX_COMBO and PREVIX_BOOST randomised controlled trials.

Leach AJ, Wilson N, Arrowsmith B, Beissbarth J, Mulholland EK, Santosham M, Torzillo PJ, McIntyre P, Smith-Vaughan H, Chatfield MD, Lehmann D, Binks M, Chang AB, Carapetis J, Krause V, Andrews R, Snelling T, Skull SA, Licciardi PV, Oguoma VM, Morris PS. Leach AJ, et al. Lancet Infect Dis. 2022 Sep;22(9):1374-1387. doi: 10.1016/S1473-3099(22)00272-9. Epub 2022 Jun 27. Lancet Infect Dis. 2022. PMID: 35772449 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

101 results

Results by year